Fairmount Funds Management logo

Fairmount Funds Management

Asset Manager

Conshohocken, Pennsylvania, US

Fairmount Funds Management LLC is an institutional accredited investor leading private placements in the biotechnology sector. The company focuses on strategic investments to support innovative therapeutic developments, with a recent notable participation in funding a robust pipeline of antibody therapeutics for inflammatory bowel disease.

Recent Transactions involving Fairmount Funds Management

Deal Target Platform Buyer Industry

Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics

Spyre Therapeutics

Aeglea BioTherapeutics

EcoR1 Capital

Fairmount Funds Management

Venrock Healthcare Capital Partners

Commodore Capital

Perceptive Advisors

RTW Investments

Cormorant Asset Management

Driehaus Capital Management

Surveyor Capital

Wellington Management Company

Undisclosed Institutional Investors

Fidelity Management and Research

RA Capital Management

DeepTrack Capital

Biotechnology Research

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →